Hilda Ampadu

Class of:

2014

Current affiliation:

Utrecht University

Contact: 

hilda.ampadu@who-acc.org

haggar.ampadu@who-pvafrica.org

Motivation:

Good data collection practices alienate the risks of using wrong or faulty data for decision-making; it is my desire to help my continent and contribute my quota to intellectual development efforts that has fueled my passion for this research.

Education and experience:

Hilda is the Deputy Director of the WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance, Accra, Ghana. She was trained as a Biologist and Data Scientist. Her research focuses on drug regulatory science and Pharmacoepidemiology for Pharmacovigilance in Africa.

Hilda worked in the United States Biotech/Pharmaceutical/Medical Device industry for 12 years mainly in the areas of Clinical Trials Management and Data Management. She relocated to her home country of Ghana in December 2012 to pursue a career in public health. She is a Certified Clinical Data Manager with the Society of Clinical Data Management.

Title PhD project:

From data collection to data transformation for decision-making: the evolution of National Pharmacovigilance Centres in Africa.

PhD project description: Weak data management practices are a critical challenge to national pharmacovigilance centres in trying to reach their goals of providing safer drugs and making informed decisions on what drugs to allow into their markets, keep on their markets and what drugs to withdraw or not allow.  This in itself poses a major safety concern to patients as decisions not based on good data and the optimal analysis and utilization of data can jeopardize the entire health system. This thesis seeks to assess data collection and data management capabilities of national centres in Africa. It will seek to establish the extent to which pharmacovigilance data is used for decision-making and examine interventions that are associated with high levels of success in data utilization for decision-making. The study will further seek to develop a model to propose a set of interventions and approaches that might facilitate the rapid transformation of African National PV Centres from data collectors to users of data for national decision-making and improvement of patient care and safety

Team members and other people involved:

The WHO Collaborating Center for Advocacy and Training in Pharmacovigilance, WHO-SAV Department, UMC

 

Publications:

Pharmacovigilance in Africa

Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®.